Lupus trials recruiting in Nevada
3
Recruiting in Nevada
1
Cities with sites
Cities in Nevada
Las Vegas 3
Recruiting trials in Nevada
- A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
- PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users